19F MR Characterization of Fluorinated Proteins and Relaxation Rate Enhancement with Gd-DTPA for Faster Imaging
Proton magnetic resonance imaging (MRI) is a well established clinical modality, which provides excellent anatomical definition. The judicious use of magnetic resonance (MR) contrast agents enhances anatomical definition and novel agents with enhanced specificity are being developed. Currently, there is a major thrust to achieve functional imaging providing local physiological parameters with high temporal and spatial resolution.
KeywordsLattice Relaxation Time Proton Magnetic Resonance Imaging Relaxation Agent Total Imaging Time Sodium Trifluoroacetate
Unable to display preview. Download preview PDF.
- 1.S.R. Thomas “The Biomedical Applications of Fluorine-19 NMR”, in: “Magnetic Resonance Imaging”, Vol II, CL. Partain et al, ed., 2nd edition, W.B. Saunders Comp., Philadelphia, 1536 (1988).Google Scholar
- 2.B.S. Selinsky, and C.T. Burt, “In Vivo 19F NMR”, in: Biological Magnetic Resonance, Vol 11, L.J. Berlinger and J. Reuben ed., Plenum Press, New York 241 (1992).Google Scholar
- 3.R.P. Mason, Non-invasive Physiology: 19F NMR of perfluorocarbons, Biomat Artif. Cells Immob. Biotechnol, 22, in the press (1994).Google Scholar
- 10.V.D. Mehta, S. Aravind, P.V. Kulkarni, R.P. Mason, and P.P. Antich, Fluorinated macromolecular probes as biosensors for non-invasive assessment of pH with magnetic resonance spectroscopy, J. Nucl. Med. 34:124 (1993).Google Scholar
- 11.V.D. Mehta, P.V. Kulkarni, R.P. Mason, A. Constantinescu, and P.P. Antich, Fluorinated proteins as new 19F magnetic resonance imaging and spectroscopy agents, 204th American Chemical Society National Meeting, (Division of Medicinal Chemistry), Washington, D.C., August 23–28, 1992.Google Scholar
- 13.J.L. Evelhoch, and J.J.H. Ackerman, NMR T1 measurements in inhomogenous B1 with surface coils, J. Magn. Reson. 53:52 (1983).Google Scholar